Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
RBMY1J - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
FRG2EP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
VWA1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
NLGN2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CXCR6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C4BPB - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AIPL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CCDC85B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SAP30L - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
PARD3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NR2F2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CRB3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PXN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FMO6P - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NIN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LINC00620 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on